Adagio Medical Inc. (ADGM)
Adagio Medical Statistics
Share Statistics
Adagio Medical has 15.38M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 15.38M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 617 |
FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 11.54K, so 0.08% of the outstanding shares have been sold short.
Short Interest | 11.54K |
Short % of Shares Out | 0.08% |
Short % of Float | 0.08% |
Short Ratio (days to cover) | 0.85 |
Valuation Ratios
The PE ratio is -0.28 and the forward PE ratio is null. Adagio Medical's PEG ratio is 0.
PE Ratio | -0.28 |
Forward PE | n/a |
PS Ratio | 56.74 |
Forward PS | null |
PB Ratio | 0.77 |
P/FCF Ratio | -0.93 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Adagio Medical.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.82.
Current Ratio | 3.27 |
Quick Ratio | 2.93 |
Debt / Equity | 0.82 |
Debt / EBITDA | -0.26 |
Debt / FCF | -0.99 |
Interest Coverage | 56.54 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $3.36K |
Profits Per Employee | $-672.04K |
Employee Count | 80 |
Asset Turnover | 0.01 |
Inventory Turnover | 0.75 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.19, so Adagio Medical's price volatility has been higher than the market average.
Beta | 0.19 |
52-Week Price Change | null% |
50-Day Moving Average | 1.04 |
200-Day Moving Average | null |
Relative Strength Index (RSI) | 43.27 |
Average Volume (20 Days) | 131.87K |
Income Statement
In the last 12 months, Adagio Medical had revenue of 269K and earned -53.76M in profits. Earnings per share was -3.7.
Revenue | 269K |
Gross Profit | -1.67M |
Operating Income | -62.48M |
Net Income | -53.76M |
EBITDA | -62.48M |
EBIT | -54.87M |
Earnings Per Share (EPS) | -3.7 |
Balance Sheet
The company has 20.59M in cash and 16.27M in debt, giving a net cash position of 4.32M.
Cash & Cash Equivalents | 20.59M |
Total Debt | 16.27M |
Net Cash | 4.32M |
Retained Earnings | -70.59M |
Total Assets | 107.2M |
Working Capital | 27.11M |
Cash Flow
In the last 12 months, operating cash flow was -15.99M and capital expenditures -368K, giving a free cash flow of -16.36M.
Operating Cash Flow | -15.99M |
Capital Expenditures | -368K |
Free Cash Flow | -16.36M |
FCF Per Share | -1.13 |
Margins
Gross margin is -620.07%, with operating and profit margins of -23226.77% and -19986.25%.
Gross Margin | -620.07% |
Operating Margin | -23226.77% |
Pretax Margin | -19986.25% |
Profit Margin | -19986.25% |
EBITDA Margin | -23226.77% |
EBIT Margin | -23226.77% |
FCF Margin | -6081.04% |
Dividends & Yields
ADGM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ADGM.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -0.19 |
Piotroski F-Score | 2 |